secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2022-06-10T23:59:59+00:00
Accession:  0001193125-22-171970
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics receives Nasdaq delisting notice for failure to meet $50M MVLS requirement
--------------------------------------------------------------------------------

- Received Nasdaq notice on June 8, 2022 for non-compliance with minimum Market Value of Listed Securities of $50M.
- Has 180 days, until December 5, 2022, to regain compliance by closing at $50M+ for 10 consecutive business days.
- Stock continues trading on Nasdaq Global Market under symbol GRTX; may consider transfer to Nasdaq Capital Market.
- No assurance of regaining compliance; failure may lead to delisting subject to appeal.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312522171970/0001193125-22-171970-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312522171970/d368942d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-171970

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer